CannaPharmaRX
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CannaPharmaRX generated cash of -$2,274,452, which is less than the previous year. Cash used in financing activities reached the amount of $2,353,419 last year. Net change in cash is therefore -$1,667.
Cash Flow
| 2014 | -1.54M | -150.72K | 3.29M |
|---|---|---|---|
| 2015 | -2.54M | 135.67K | 810.47K |
| 2016 | -22.38K | 0 | 19.75K |
| 2017 | 0 | 0 | 0 |
| 2018 | -941.13K | -726.74K | 2.13M |
| 2019 | -3.79M | -46.93K | 3.26M |
| 2020 | -563.57K | 0 | 824.57K |
| 2021 | -2.41M | 493.62K | 1.30M |
| 2022 | -1.44M | -115.99K | 1.40M |
| 2023 | -2.27M | -80.63K | 2.35M |
CPMD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.31K | 27.76K | 334.96K | 1.54K | 464.11K | -1.66M | 0 | 2.62K | 1.60M | 0 |
Operating activities | ||||||||||
Net income | 3.68M | -8.53M | -8.83M | -19.89M | -20.45M | -3.09M | -6.63K | -1.00M | -11.74M | -3.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 127.84K | 294.93K | 2.70K | 128.50K | 129.03K | 2.07M | 0 | 0 | 12.03K | 3.02K |
Stock-based compensation expense | 0 | 180.97K | 363.05K | 820.37K | 736.18K | 0 | 0 | 728.12K | 7.43M | 579.56K |
| Deferred income tax benefit | 0 | 180.97K | 363.05K | 820.37K | 736.18K | 0 | 0 | 728.12K | 7.43M | 579.56K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -38.27K | -21.59K | -1.21K | 28.38K | 0 | 0 | 0 | 0 | 531 | 0 |
Inventories | -1.13M | 21.59K | 1.21K | -28.38K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 129.98K | 1.42M | -449.66K | 1.70M | 371.22K | 120.1K | 4.96K | 7.77K | 319.73K | 290.56K |
Cash generated by operating activities | -2.27M | -1.44M | -2.41M | -563.57K | -3.79M | -941.13K | 0 | -22.38K | -2.54M | -1.54M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -39.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -80.63K | -115.99K | -6.26K | 0 | -46.93K | 0 | 0 | 0 | -2.07K | -100.72K |
Acquisitions Net | 0 | 0 | 539.37K | 0 | 0 | -726.74K | 0 | 0 | 50K | -50K |
Cash generated by investing activities | -80.63K | -115.99K | 493.62K | 0 | -46.93K | -726.74K | 0 | 0 | 135.67K | -150.72K |
Financing activities | ||||||||||
Common Stock Issued | 19.99K | 437.01K | 826.06K | 0 | 0 | 60K | 0 | 0 | 804.67K | 3.33M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -39.49K | 0 | -98.95K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -238.56K | -35.4K | 2.89M | -2.07M | 0 | -19.75K | 0 | 0 |
Cash used in financing activities | 2.35M | 1.40M | 1.30M | 824.57K | 3.26M | 2.13M | 0 | 19.75K | 810.47K | 3.29M |
Net Change In Cash | -1.66K | -25.45K | -307.20K | 333.42K | -462.57K | 2.13M | 0 | -2.62K | -1.60M | 1.60M |
Cash at end of period | 650 | 2.31K | 27.76K | 334.96K | 1.54K | 464.11K | 0 | -1 | 2.62K | 1.60M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |